UniSa - IRIS Institutional Research Information System

BARONE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 35.211
NA - Nord America 26.113
EU - Europa 10.394
SA - Sud America 2.477
Continente sconosciuto - Info sul continente non disponibili 1.121
AF - Africa 301
OC - Oceania 211
Totale 75.828
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.513
HK - Hong Kong 23.367
SG - Singapore 5.240
IT - Italia 4.233
CN - Cina 2.587
BR - Brasile 1.840
VN - Vietnam 1.749
UA - Ucraina 1.442
RU - Federazione Russa 950
DE - Germania 879
IE - Irlanda 654
FR - Francia 561
KR - Corea 485
TR - Turchia 443
SE - Svezia 357
FI - Finlandia 324
CA - Canada 313
GB - Regno Unito 312
BD - Bangladesh 294
IN - India 270
AR - Argentina 235
MX - Messico 149
EE - Estonia 146
JP - Giappone 131
IQ - Iraq 105
NZ - Nuova Zelanda 105
NL - Olanda 102
AU - Australia 100
EC - Ecuador 96
PL - Polonia 85
CO - Colombia 84
ZA - Sudafrica 74
ES - Italia 72
PK - Pakistan 72
ID - Indonesia 69
AT - Austria 65
VE - Venezuela 63
UZ - Uzbekistan 52
CL - Cile 51
MA - Marocco 50
PY - Paraguay 41
MY - Malesia 39
SA - Arabia Saudita 38
CZ - Repubblica Ceca 34
KE - Kenya 32
PH - Filippine 29
IL - Israele 25
JM - Giamaica 24
EG - Egitto 23
AE - Emirati Arabi Uniti 22
AZ - Azerbaigian 22
PE - Perù 22
UY - Uruguay 21
BO - Bolivia 20
CH - Svizzera 20
CR - Costa Rica 20
DZ - Algeria 20
ET - Etiopia 20
JO - Giordania 19
DO - Repubblica Dominicana 18
LT - Lituania 18
EU - Europa 16
AL - Albania 15
OM - Oman 15
TN - Tunisia 15
BE - Belgio 14
LB - Libano 14
NP - Nepal 14
HN - Honduras 13
KZ - Kazakistan 13
BG - Bulgaria 12
PR - Porto Rico 10
BA - Bosnia-Erzegovina 9
MN - Mongolia 9
NI - Nicaragua 9
PS - Palestinian Territory 9
PT - Portogallo 9
BW - Botswana 8
BY - Bielorussia 8
GE - Georgia 8
GR - Grecia 8
IR - Iran 8
SV - El Salvador 8
CI - Costa d'Avorio 7
DK - Danimarca 7
HU - Ungheria 7
PA - Panama 7
BH - Bahrain 6
GT - Guatemala 6
KG - Kirghizistan 6
KH - Cambogia 6
QA - Qatar 6
RS - Serbia 6
SN - Senegal 6
SY - Repubblica araba siriana 6
MD - Moldavia 5
ME - Montenegro 5
MK - Macedonia 5
NG - Nigeria 5
NO - Norvegia 5
Totale 74.591
Salva come PNG Salva come JPEG
Città #
Hong Kong 23.335
Ann Arbor 4.156
Singapore 2.552
San Jose 2.353
Wilmington 2.255
Jacksonville 1.735
Milan 1.717
Princeton 1.636
Chandler 1.536
Ashburn 1.288
Dallas 1.208
Houston 760
Woodbridge 618
Dublin 614
Council Bluffs 583
Beijing 562
The Dalles 490
Lauterbourg 479
Dong Ket 459
Rome 428
Ho Chi Minh City 414
Nanjing 399
Andover 368
Izmir 365
Los Angeles 349
Moscow 316
Boardman 299
New York 299
Hanoi 294
Pellezzano 264
Santa Clara 264
Düsseldorf 216
Mestre 203
Naples 188
São Paulo 168
Tallinn 146
Norwalk 144
Figino 138
Shenyang 134
Fairfield 131
Buffalo 130
Salerno 126
Hebei 121
Munich 121
Tokyo 117
Memphis 116
Changsha 113
Nanchang 108
Dearborn 107
Frankfurt am Main 94
Jiaxing 85
Turin 78
Montreal 77
Chicago 73
Brooklyn 72
Da Nang 69
Orem 68
Warsaw 66
Nuremberg 65
Rio de Janeiro 61
Redwood City 60
Haiphong 58
San Francisco 57
Pune 56
Tianjin 56
San Diego 54
Amsterdam 53
Atlanta 49
Columbus 49
Seattle 49
Tashkent 47
Mexico City 45
Stockholm 45
Baghdad 44
Phoenix 44
Auckland 43
Sydney 43
Boston 42
Curitiba 42
Denver 42
Washington 40
Belo Horizonte 39
Seoul 39
Bologna 38
Chennai 38
London 37
Toronto 37
Brasília 36
Turku 35
West Jordan 35
Johannesburg 34
Charlotte 33
Cambridge 32
Poplar 31
Shanghai 31
Ottawa 30
Quito 30
Jinan 29
Casoria 28
Guangzhou 28
Totale 57.388
Salva come PNG Salva come JPEG
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 1.196
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 1.005
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 967
Managing Device-Aided Treatments in Parkinson's Disease in Times of COVID-19 937
Trial of Deferiprone in Parkinson's Disease 690
Sex Differences in Parkinson’s Disease: From Bench to Bedside 652
Quantitative gait assessment in Parkinsonian patients with or without Mild Cognitive Impairment 621
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 604
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 598
Cognitive impairment in nondemented Parkinson's disease. 585
Gender differences in microRNA expression in levodopa-naive PD patients 580
Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease. 551
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 549
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. 546
A simulation tool to plan daily nurse requirements 537
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 533
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 532
Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclearpalsy. 523
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 518
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. Apr 30;24(6):899-905.PMID: 19205072 484
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 470
Quality of Life and Nonmotor Symptoms in Parkinson's Disease 465
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 460
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry 451
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 440
Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease. 440
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 424
Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation 416
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 407
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. 404
Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status 396
Neurotransmission in Parkinson's disease: beyond dopamine. 380
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 379
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 361
Effects of Safinamide on Pain in Fluctuating Parkinson's Disease Patients: A Post-Hoc Analysis 356
Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review 342
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 333
Bilateral facial palsy after COVID-19 vaccination 331
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 330
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson'sdisease in Italians 329
Clinical and Molecular Characterization of a Novel Progranulin Deletion Associated with Different Phenotypes 329
Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial 316
Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy 316
A novel phenotype in an Italian family with a rare progranulin mutation 313
Association study between the LINGO1 gene and Parkinson's disease in the Italian population 302
Trial of Cinpanemab in Early Parkinson's Disease 299
Dual-task-related gait patterns as possible marker of precocious and subclinical cognitive alterations in Parkinson disease 297
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 291
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease 280
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 279
Classifying Different Stages of Parkinson’s Disease Through Random Forests 272
Validation of the Italian version of Parkinson's Disease-Cognitive Rating Scale (PD-CRS) 266
Metabolomics in Parkinson's disease 263
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 251
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 248
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 245
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 226
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 217
Apoptotic mechanisms in mutant LRRK2-mediated cell death. 215
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 214
Progression of multiple system atrophy (MSA): a prospective natural history studyby the European MSA Study Group (EMSA SG) 210
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 209
Personality in Parkinson's disease: Clinical, behavioural and cognitive correlates 208
The natural history of multiple system atrophy: A prospective European cohort study 205
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 204
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study 201
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study 200
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 200
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 198
Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson's disease. 196
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease. 193
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 192
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 187
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 186
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. 183
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 183
Accuracy of clinical diagnostic criteria for Friedreich'sataxia. 181
Measurements of Postural Sway to Classify Freezing of Gait in Parkinson's Disease 179
Adherence to anti-Parkinson drug therapy in the ?REASON? sample of Italian patients with Parkinson?s disease: the linguistic validation of the Italian version of the ?Morisky Medical Adherence scale-8 items? 179
Application of the mPSPRS to the Salerno Cohort and a Comparison Between PSP-RS and vPSP 179
SAND: a Screening for Aphasia in NeuroDegeneration. Development and normative data 178
Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson’s Disease 178
Cerebellar ataxia associated with subclinical celiac disease responding togluten-free diet 176
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 171
LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study 170
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 169
A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients 167
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 167
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 166
Serum miR-30c-5p is a potential biomarker for multiple system atrophy 166
Biomechanics Parameters of Gait Analysis to Characterize Parkinson's Disease: A Scoping Review 161
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 159
APP-Related Corticobasal Syndrome: Expanding the List of Corticobasal Degeneration Look Alikes 159
Affective theory of mind in patients with Parkinson's disease: comment 158
Are granular osmiophilic material deposits an epiphenomenon in CADASIL? 158
Normative data for the Montreal Cognitive Assessment in an Italian population sample 158
Essential tremor plus rest tremor: current concepts and controversies 157
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 156
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 155
Quitting smoking: An early non-motor feature of Parkinson's disease? 154
Totale 33.717
Salva come PNG Salva come JPEG
Categoria #
all - tutte 222.396
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 222.396
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.601 0 4 14 25 23 16 40 112 405 368 356 1.238
2022/20234.002 472 174 97 355 656 927 20 382 628 18 187 86
2023/20242.059 159 310 110 162 100 197 86 131 71 138 175 420
2024/20256.305 260 60 145 369 216 669 731 686 911 692 741 825
2025/202643.681 4.870 11.165 9.973 1.342 2.392 1.264 4.019 842 1.108 2.363 796 3.547
2026/20271.112 1.099 13 0 0 0 0 0 0 0 0 0 0
Totale 75.828